PUBLISHER: The Business Research Company | PRODUCT CODE: 1830729
PUBLISHER: The Business Research Company | PRODUCT CODE: 1830729
Cell therapy raw materials refer to the essential substances and components used in the development, production, and processing of cell-based therapies. These materials ensure the quality, consistency, and safety of cell cultures throughout all stages of therapy manufacturing.
The primary types of cell therapy raw materials include stem cell-based raw materials, gene therapy raw materials, and CAR-T cell therapy raw materials. Stem cell-based raw materials are specialized substances that support the growth, maintenance, and differentiation of stem cells during cell therapy research and production. These materials include media, sera, cell culture supplements, antibodies, reagents, buffers, and more, and are primarily used by biopharmaceutical and pharmaceutical companies, contract research and manufacturing organizations, and other related end users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The cell therapy raw materials market research report is one of a series of new reports from The Business Research Company that provides cell therapy raw materials market statistics, including the cell therapy raw materials industry's global market size, regional shares, competitors with the cell therapy raw materials market share, detailed cell therapy raw materials market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy raw materials market. This cell therapy raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cell therapy raw materials market size has grown exponentially in recent years. It will grow from $4.20 billion in 2024 to $5.07 billion in 2025 at a compound annual growth rate (CAGR) of 20.6%. The growth in the historic period can be attributed to the expanding presence of contract development and manufacturing organizations (CDMOs), the rising prevalence of autoimmune and genetic disorders, increasing government and private funding, heightened focus on scalable manufacturing processes, and the growing number of clinical trials.
The cell therapy raw materials market size is expected to see exponential growth in the next few years. It will grow to $10.61 billion in 2029 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to the rising demand for regenerative medicine, increasing adoption of personalized therapies, growing investment in cell and gene therapy research and development, expanding approvals of cell-based therapies, and heightened awareness of advanced therapy medicinal products (ATMPs). Major trends during this period include advancements in cell culture technologies, integration of automation in bioprocessing, development of xeno-free and chemically defined media, innovations in cryopreservation techniques, and adoption of closed-system bioreactors.
The growing use of regenerative medicine is expected to propel the growth of the cell therapy raw materials market going forward. Regenerative medicine focuses on restoring or establishing normal function by replacing, engineering, or regenerating human cells, tissues, or organs. Its adoption is increasing due to the rising burden of chronic and degenerative diseases, which drive demand for therapies that repair or replace damaged tissues rather than merely manage symptoms. Cell therapy raw materials provide essential components-such as growth factors, cell culture media, enzymes, and scaffolds-needed to cultivate, expand, and maintain therapeutic cells used to repair or regenerate damaged tissues. For instance, in January 2025, the National Library of Medicine, a US-based biomedical library, reported that 32 new gene therapies, including genetically modified cell therapies, were approved in 2024. Therefore, the growing use of regenerative medicine is driving the growth of the cell therapy raw materials market.
Prominent companies in the cell therapy raw materials market are focusing on innovation and GMP-compliant manufacturing to ensure product safety, consistency, and regulatory adherence. Good manufacturing practice (GMP)-compliant manufacturing ensures products are consistently produced according to quality standards set by regulatory authorities, minimizing risks in pharmaceutical and biotechnological production. For instance, in April 2025, Thermo Fisher Scientific Inc., a US-based life sciences and clinical research company, launched an Advanced Therapies Collaboration Center (ATxCC) in the U.S. to support cell and gene therapy development. The center provides end-to-end cGMP manufacturing support, advanced technologies, and process optimization, accelerating development and commercialization.
In January 2025, Charles River Laboratories International Inc., a US-based pharmaceutical company, partnered with Akron Biotechnology to enhance cell therapy manufacturing. The partnership incorporated cGMP-compliant cytokines into Charles River's Flex Platform, streamlining processing, improving scalability, and ensuring regulatory compliance for advanced therapies. Akron Biotechnology is a US-based manufacturer specializing in raw materials for cell and gene therapy development.
Major players in the cell therapy raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, Corning Incorporated, Lonza Group AG, Grifols SA, Wuxi AppTec Co. Ltd., Charles River Laboratories International Inc., Sartorius Stedim Biotech SA, Bio-Techne Corporation, Stemcell Technologies Inc., Miltenyi Biotec GmbH, Actylis, ACROBiosystems Co Ltd., BioIVT LLC, FUJIFILM Cellular Dynamics, CellGenix GmbH, Promocell GmbH, RoosterBio Inc., and Akron Biotech LLC.
North America was the largest region in the cell therapy raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell therapy raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cell therapy raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell therapy raw materials market consists of sales of serum and serum-free supplements, cryopreservation systems, and buffer systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Therapy Raw Materials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cell therapy raw materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cell therapy raw materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell therapy raw materials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.